Pregabalin Completed Phase 4 Trials for Schizophrenic Disorders / Anxiety-comorbidity to Schizophrenia Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01496690Pregablin for Anxiety-comorbidity in Patients With Schizophrenia